59th Annual Meeting
Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.


New Research Poster 4 (open)
New Research Poster Session 4

Friday, October 26, 2012: 9:30 AM-12:00 PM
 
4.1
Is a Urine Drug Screen Necessary Prior to Randomizing Youth for a Clinical Trial of Treatment Resistant Depression?
Victoria I. Pham, D.O. University of Pittsburgh Medical Center and New York Presbyterian, University Hospitals of Columbia and Cornell, New York, NY
David Brent, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Giovanna Porta, M.S. Western Psychiatric Institute and Clinic, Pittsburgh, PA
 
4.2
Mental Health Problems and Treatment Needs of Child Welfare Involved Youth in a Randomized Effectiveness Trial of Modular EBP
J. Lindsey Tweed, M.D., M.P.H. Office of Child and Family Services, Augusta, ME
Daniel M. Cheron, Ph.D. Judge Baker Children's Center, Boston, MA
Jennifer A. Herren, Ph.D. Judge Baker Children's Center, Boston, MA
Virginia S. Marriner, B.A. Office of Child and Family Services, Augusta, ME
John R. Weisz, Ph.D. Judge Baker Children's Center, Boston, MA
 
4.3
Child and Adolescent Psychiatric Service for Patients with ADHD Complicated by Oppositional Defiant Disorder
Kumi Yuki, M.D. Mayo Clinic, Rochester, MN
Jyoti Bhagia, M.D. Mayo Clinic, Rochester, MN
Peter S. Jensen, M.D. Mayo Clinic, Rochester, MN
 
4.4
Methylphenidate Patch for ADHD: Wear Time and Subtype Response
L. Eugene Arnold, M.D. Ohio State University, Sunbury, OH
 
4.5
Neurodevelopmental Trajectories Differ in Children with and without ADHD During Response Inhibition
Adriana Galván, Ph.D. University of California, Los Angeles, Los Angeles, CA
Kevin Terashima, B.S. University of California, Los Angeles, Los Angeles, CA
Catherine Hegarty, B.A. University of California, Los Angeles, Los Angeles, CA
Eric Miller, B.S. University of California, Los Angeles, Los Angeles, CA
Russell A. Poldrack, Ph.D. The University of Texas at Austin, Austin, TX
Robert M. Bilder, Ph.D. University of California, Los Angeles, Los Angeles, CA
James McGough, M.D. UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Susan Y. Bookheimer, Ph.D. University of California, Los Angeles, Los Angeles, CA
James T. McCracken, M.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
 
4.6
The Association Between Physician Perception of Treatment Outcome and Patient Comorbidity Burden in Children and Adolescents with ADHD Across European Union Countries
Juliana Setyawan, Pharm.D. Shire Development LLC, Wayne, PA
Vanja Sikirica, M.P.H., Pharm.D. Shire Development LLC, Wayne, PA
Moshe Fridman, Ph.D. AMF Consulting, Los Angeles, CA
Paul Hodgkins, M.S.C., Ph.D. Shire Development LLC, Wayne, PA
M. Haim Erder, Ph.D. Shire Development LLC, Wayne, PA
 
4.7
The Economic Burden of Incremental Direct and Indirect Societal Costs Associated with ADHD in the U.S.
Paul Hodgkins, M.S.C., Ph.D. Shire Development LLC, Wayne, PA
Jalpa A. Doshi, Ph.D. University of Pennsylvania, Philadelphia, PA
Vanja Sikirica, M.P.H., Pharm.D. Shire Development LLC, Wayne, PA
Juliana Setyawan, Pharm.D. Shire Development LLC, Wayne, PA
M. Haim Erder, Ph.D. Shire Development LLC, Wayne, PA
Jennifer Kahle, Ph.D. BPS International, San Diego, CA
Michael Cangelosi, M.A., M.P.H. Tufts Medical Center, Boston, MA
Peter Neumann, DSc Tufts Medical Center, Boston, MA
 
4.8
Bioequivalence Study Comparing Atomoxetine Oral Solution and Capsule Formulation in Healthy Adult Male Subjects
Masako Nakano, M.D., Ph.D. Eli Lilly and Company, Kobe Japan
Jennifer W. Witcher, Ph.D. Eli Lilly and Company, Indianapolis, IN
Yoichi Satoi, B.S. Eli Lilly and Company, Kobe Japan
Keisuke Shinkai, M.S. Eli Lilly and Company, Kobe Japan
Taro Goto, M.D., Ph.D. Eli Lilly and Company, Indianapolis, IN
 
4.9
ADHD As a Risk Factor for Obesity: Search for Possible Mechanisms
Ellen A. Fliers, M.D., Ph.D. University Medical Center Nijmegen, Nijmegen Netherlands
Jan K. Buitelaar, Ph.D. Radboud University Nijmegen Medical Center, Nijmegen Netherlands
Barbara Franke, Ph.D. University Medical Center Nijmegen, Nijmegen Netherlands
Athanasios Maras, M.D., Ph.D. Yulius Academy, Rotterdam Netherlands
Kim Bul, M.S.C. Yulius Academy, Rotterdam Netherlands
Esther Hohle, M.S. Yulius Academy, Rotterdam Netherlands
Stephen V. Faraone, Ph.D. SUNY Upstate Medical University, Syracuse, NY
Nanda N. Rommelse, Ph.D. Radboud University Nijmegen Medical Centre, Nijmegen Netherlands
 
4.10
Do ADHD Subtypes Differ Significantly in Levels of Parenting Stress?
Alan McLuckie, Ph.D. Sun Life Chair in Adolescent Mental Health Group/Dalhousie University, Halifax, NS
Katherine Matheson, M.D. Dalhousie University, Halifax, NS
Melissa Rowbotham, M.A. Integra, Toronto, ON
David Ng, M.D. Scarborough Hospital, Toronto, ON
Michael Schwartz, Ph.D. Psychologist in Private Practice, Thornhill, ON
 
4.11
The Impact of ADHD on Neuropsychological Development in Early Adolescence: A Longitudinal Case Control Study
David A. Hayward, M.B.B.S., M.R.C.Psych. NHS Tayside, Perth United Kingdom
Sinead M. Rhodes, Ph.D. University of Strathclyde, Glasgow United Kingdom
Keith Matthews, M.D., Ph.D. University of Dundee, Dundee United Kingdom
David Coghill, M.D., F.R.C.Psych., MBChB Ninewells Hospital, Dundee Scotland
 
4.12
Perceived Benefits From Methylphenidate Among Young Adults with ADHD While Driving in the Evening
Daniel J. Cox, Ph.D. University of Virginia, Charlottesville, VA
Richard L. Merkel, M.D. University of Virginia, Charlottesville, VA
J.Quyen Vu Alexander Nichols University of Virginia, Charlottesville, VA
Ronald Johnson University of Virginia, Charlottesville, VA
 
4.19
ADHD, Comorbid Oppositional Defiant Disorder and Anxiety Disorders, and Caregiver Stress, Strain and Depression
Sarah Grover, B.A. Seattle Children's Research Institute, Seattle, WA
Carol Rockhill, M.D., M.P.H., Ph.D. Seattle Children's Hospital Bellevue, Bellevue, WA
Heather Violette, Ph.D. Seattle Children's Research Institute, Seattle, WA
Ann Vander Stoep, Ph.D. University of Washington School of Medicine and Public Health, Seattle, WA
Kathleen Myers, M.D., M.P.H., M.S. University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA
 
4.20
Treatment Modalities for Latino Youth with ADHD According to Comorbidity and Length of Treatment in Psychiatric Public Clinics
Luis J. Olivera-Rodríguez, M.D., M.P.H. Univeristy of Puerto Rico School of Medicine, San Juan, PR
Stephanie D. Rivera-Segarra, M.D. University of Puerto Rico Shcool of Medicine, San Juan, PR
Roxanne Fuentes-Blanco, B.A. Universidad Metropolitana, San Juan, PR
Juan Carlos Jorge, Ph.D. University of Puerto Rico School of Medicine, San Juan, PR
Gloria González-Tejera, M.D. University of Puerto Rico School of Medicine, San Juan, PR
 
4.21
ERP Correlates of Abnormal Conflict Monitoring in Children with ADHD: Effects of Long-Term Treatment
Mario Liotti, M.D., Ph.D. Simon Fraser University, Burnaby Canada
Steven R. Pliszka, M.D. The University of Texas Health Science Center at San Antonio, San Antonio, TX
Delia Kothmann-Paskos, Ph.D. St. Edward's University, Austin, TX
Ricardo Perez III, B.S. University of Texas Health Science Center, San Antonio, TX
Margaret Semrud-Clikeman, Ph.D. University of Minnesota, Minneapolis, MN
 
4.22
Comorbidity of Psychiatric Disorders in a Clinic Sample of Nigerian Children with ADHD
Increase I. Adeosun, M.D. Federal Neuro-Psychiatric Hospital Yaba, Lagos Nigeria
Oluwayemi C. Ogun, M.D., M.S.C. Federal Neuro-Psychiatric Hospital Yaba, Lagos Nigeria
Temitayo G. Ijarogbe, M.D. Federal Neuro-Psychiatric Hospital Yaba, Lagos Nigeria
 
4.23
Sex-Specific White Matter Correlates of ADHD
Shirag K. Shemmassian, M.A. University of California, Los Angeles, Los Angeles, CA
Jesse A. Brown, B.S. University of California, Los Angeles, Los Angeles, CA
Adriana Galván, Ph.D. University of California, Los Angeles, Los Angeles, CA
Russell A. Poldrack, Ph.D. The University of Texas at Austin, Austin, TX
Steve S. Lee, Ph.D. University of California, Los Angeles, Los Angeles, CA
Robert M. Bilder, Ph.D. University of California, Los Angeles, Los Angeles, CA
James McGough, M.D. UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Susan Y. Bookheimer, Ph.D. University of California, Los Angeles, Los Angeles, CA
James T. McCracken, M.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
 
4.24
You Heard It Here First! A Year in the Life of the Child Psychopharm Listserve
Howard Rudominer, M.D. New York University Langone Medical Center, New York, NY
Allison S. Baker, M.D. New York Presbyterian Hospital, Columbia University Medical Center, Cornell University Hospital, New York, NY
Timothy Eric Spiegel, M.D. Washington University, Kirkwood, MO
Avanti RB Bergquist, M.D. University of Washington, Seattle, WA
Nanelle Jones-Sullivan, M.D. Private practice and Solano County Mental Health, Vacaville, CA
 
4.25
Automated Monitoring of Pre-Kindergarten Children in a Classroom Setting for Screening and Risk Marker Discovery
Nicholas Walczak University of Minnesota, Minneapolis, MN
Joshua Fasching University of Minnesota, Minneapolis, MN
Kathryn R. Cullen, M.D. University of Minnesota Medical School, Minneapolis, MN
Barbara Murphy, Ph.D. University of Minnesota, Minneapolis, MN
Guillermo Sapiro, Ph.D. University of Minnesota, Minneapolis, MN
Vassilios Morellas, Ph.D. University of Minnesota, Minneapolis, MN
Nikolaos Papanikolopoulos, Ph.D. University of Minnesota, Minneapolis, MN
 
4.26
Automatically Aiding the Assessment of Atypical Motor Patterns for Autism Spectrum Disorder Diagnosis
Thiago Vallin Spina, B.S. University of Campinas, Campinas, São Paulo
Jordan K. Hashemi, B.S. University of Minnesota, Minneapolis USA
Mariano Tepper, Ph.D. University of Minnesota, Minneapolis, MN
Amy Esler, Ph.D. University of Minnesota, Minneapolis, MN
Vassilios Morellas, Ph.D. University of Minnesota, Minneapolis, MN
Nikolaos Papanikolopoulos, Ph.D. University of Minnesota, Minneapolis, MN
Guillermo Sapiro, Ph.D. University of Minnesota, Minneapolis, MN
 
4.27
A Computer Vision Approach for Aiding in the Autism Observation Scale for Infants Test: Automatic Monitoring of Visual Attention
Jordan K. Hashemi, B.S. University of Minnesota, Minneapolis USA
Thiago Vallin Spina, B.S. University of Campinas, Campinas, São Paulo
Mariano Tepper, Ph.D. University of Minnesota, Minneapolis, MN
Amy Esler, Ph.D. University of Minnesota, Minneapolis, MN
Vassilios Morellas, Ph.D. University of Minnesota, Minneapolis, MN
Nikolaos Papanikolopoulos, Ph.D. University of Minnesota, Minneapolis, MN
Guillermo Sapiro, Ph.D. University of Minnesota, Minneapolis, MN
 
4.28
An Online Virtual World to Support Military Children and Families
Stephen Cozza, M.D. Center for the Study of Traumatic Stress, Uniformed Services University, Bethesda, MD
Patricia Lester, M.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
Sara Pula, M.A. Uniformed Services University of the Health Sciences, Bethesda, MD
Julie D'Amico, M.A. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
April M. Harris, M.S. Uniformed University of the Health Sciences, Bethesda, MD
Catherine Mogil, Psy.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
Freda Denis-Cooper, B.S. Uniformed Services University of the Health Sciences, Bethesda, MD
 
4.29
A Pilot Treatment Study of Fluoxetine for Obsessive Compulsive Disorder in Children and Adolescents with Bipolar Disorder
Gagan Joshi, M.D. Massachusetts General Hospital, Boston, MA
Janet Wozniak, M.D. Massachusetts General Hospital, Cambridge, MA
Daniel Geller, M.D. Massachusetts General Hospital, Newton, MA
MaryKate Martelon, M.P.H. Massachusetts General Hospital, Boston, MA
Rachel Goldin, B.A. Massachusetts General Hospital, Cambridge, MA
Stephannie Furtak, B.A. Massachusetts General Hospital, Cambridge, MA
Joseph Biederman, M.D. Massachusetts General Hospital, Boston, MA
 
4.30
Neuropsychological Functioning in Children with Obsessive Compulsive Disorder, Their Siblings, and Controls
Andrea Victor, Ph.D. Rush University Medical Center, Skokie, IL
Gail A. Bernstein, M.D. University of Minnesota Medical School, Minneapolis, MN
Peter M. Nelson, M.A. University of Minnesota, Minneapolis, MN
Irving Gottesman, A.B.P.P., F.R.C.Psych., Ph.D. University of Minnesota, Minneapolis, MN
 
4.31
Temper Outbursts in Pediatric Obsessive Compulsive Disorder
Koen Bolhuis, B.S. Institute of Psychiatry, King's College London, London United Kingdom
 
4.32
Functional Impairment and Outcome of Obsessive Compulsive Disorder Symtoms Across Three Years in a Clinical Sample of Swedish Children and Adolescents
Karin A. Melin, M.S., R.N. Sahlgrenska University Hospital, Gothenburg Sweden
Bente S.M. Haugland, Ph.D. Regional Centre for Child and Youth Mental Health and Child Welfare, Bergen Norway
Ingela Skärsäter, Ph.D., R.N. The Sahlgrenska Academy at University of Gothenburg, Faculty of Health and Caring Sciences, Gothenburg Sweden
Tord Ivarsson, M.D., Ph.D. Centre for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo Norway
 
4.33
Altered White Matter Architecture of Children and Adolescents with Obsessive Compulsive Disorder
Luisa Lázaro, M.D., Ph.D. Hospital Clinic Barcelona, Barcelona Spain
Anna Calvo, M.S. Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona Spain
Ana Griselda Ortiz Hospital Clinic Barcelona, Barcelona Spain
Elena Moreno Hospital Clinic Barcelona, Barcelona Spain
M. Teresa Plana, M.D. Hospital Clinic Barcelona, Barcelona Spain
Astrid Morer, M.D., Ph.D. Child and Adolescent Psychiatry and Psychology Department, Institut Clinic de Neurociències, IDIBAPS, Hospital Clinic, Cibersam, Barcelona Spain
Elena Font Hospital Clinic Barcelona, Barcelona Spain
Rosa Calvo, M.D., Ph.D. Hospital Clinic Barcelona, Barcelona Spain
Nuria Bargallo, M.D. Hospital Clinic Barcelona, Barcelona Spain
 
4.34
Decreased Grey Matter Volume in Fronto-Parietal Regions in Children and Adolescents with Obsessive Compulsive Disorders
Luisa Lázaro, M.D., Ph.D. Hospital Clinic Barcelona, Barcelona Spain
Ana Griselda Ortiz Hospital Clinic Barcelona, Barcelona Spain
Anna Calvo, M.S. Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona Spain
Elena Moreno Hospital Clinic Barcelona, Barcelona Spain
M. Teresa Plana, M.D. Hospital Clinic Barcelona, Barcelona Spain
Astrid Morer, M.D., Ph.D. Child and Adolescent Psychiatry and Psychology Department, Institut Clinic de Neurociències, IDIBAPS, Hospital Clinic, Cibersam, Barcelona Spain
Elena Font Hospital Clinic Barcelona, Barcelona Spain
Rosa Calvo, M.D., Ph.D. Hospital Clinic Barcelona, Barcelona Spain
Nuria Bargallo, M.D. Hospital Clinic Barcelona, Barcelona Spain
 
4.35
A Randomised Controlled Trial of Telephone Cognitive Behaviour Therapy (CBT) Versus Face-to-Face CBT in the Treatment of Obsessive Compulsive Disorder (OCD) in Young People
Cynthia Turner, Ph.D. Institute of Psychiatry, London United Kingdom
David Mataix-Cols, Ph.D. Institute of Psychiatry, London United Kingdom
Karina Lovell University of Manchester, Manchester United Kingdom
Katie Lang, B.S., M.S.C. South London and Maudesly NHS Foundation Trust, London United Kingdom
Georgina Krebs, Psy.D. South London and Maudsley NHS Foundation Trust, London United Kingdom
Sarah Byford, Ph.D. Institute of Psychiatry, London United Kingdom
Isobel Heyman, F.R.C.Psych., M.B.B.S., Ph.D. Institute of Psychiatry and Maudsley Hospital, London, London United Kingdom
 
4.36
Parenting Styles and Behaviors Associated with Obsessive Compulsive Disorder in Children
Zobeida M. Diaz, M.D., M.S. The Warren Alpert Medical School of Brown University, Providence, RI
Abbe M. Garcia, Ph.D. Brown University and Rhode Island Hospital, Providence, RI
Krishnapriya Josyula, B.A. The Warren Alpert Medical School of Brown University, Providence, RI
 
4.37
Long-Term Effects of Methylphenidate On the Cardiovascular System in Children with ADHD
Andrea G. Ludolph, M.D. University of Ulm, Ulm Germany
Julia Popp University of Ulm, Ulm Germany
Katrin Boeckmann University of Ulm, Ulm Germany
Rita Kleinrahm University of Ulm, Ulm Germany
Ferdinand Keller, Ph.D. University of Ulm, Ulm Germany
Paul Plener, M.D. University of Ulm, Ulm Germany
Ulrike M. Schulze, M.D. University of Ulm, Ulm Germany
Marc Allroggen, M.D. University of Ulm, Ulm Germany
Joerg M. Fegert, M.D., Ph.D. University of Ulm, Ulm Germany
 
4.38
Effects of Methylphenidate On Height and Weight: A Retrospective Chart Review of 111 Patients
Andrea G. Ludolph, M.D. University of Ulm, Ulm Germany
Katrin Boeckmann University of Ulm, Ulm Germany
Rita Kleinrahm University of Ulm, Ulm Germany
Julia Popp University of Ulm, Ulm Germany
Ferdinand Keller, Ph.D. University of Ulm, Ulm Germany
Ulrike M. Schulze, M.D. University of Ulm, Ulm Germany
Paul Plener, M.D. University of Ulm, Ulm Germany
Marc Allroggen, M.D. University of Ulm, Ulm Germany
Joerg M. Fegert, M.D., Ph.D. University of Ulm, Ulm Germany
 
4.39
Prevalence of Breastfeeding in ADHD Vs. Non-ADHD Children Ages 3-5: Analysis of 2007 National Health Survey Data
Rachel Goldberg, M.D. Cohen Children's Medical Center, New Hyde Park, NY
Andrew Adesman, M.D. Cohen Children's Medical Center, Lake Success, NY
Suzanne Sunday, Ph.D. Biostatistics, Feinstein Institute for Med. Rsrch, Manhassat, NY
 
4.40
Baseline Stop Signal Reaction Times and Motor Cortex Physiology by Atomoxetine Response in Children with ADHD
Floyd Sallee, M.D. University of Cincinnati, Cincinnati, OH
Steve Wu, M.D. Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
Nasrin Shahana, M.B.B.S. Cincinnati Childrens Hospital, Cincinnati, OH
David Huddleston, B.A. Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
Donald L. Gilbert, M.D., M.S. Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
 
4.41
Recognition of Facial and Emotion Patterns in Children with ADHD and Autism Spectrum Disorders
Cristina Peddis, M.D. University of Cagliari, Child Neuropsychiatry Unit and Cagliari University Hospital, Italy, Cagliari Italy
Sara Carucci, M.D. Cagliari University Hospital Center for Pharmacological Therapies in Child and Adolescent Neuropsychiatry, Cagliari Italy
Silvia Petza, Psy.D. University of Cagliari, Monserrato Italy
Gianluigi Melis, M.D. Cagliari University Hospital, Italy, Cagliari Italy
Joseph Sergeant, Ph.D. Amsterdam Free University, Amsterdam Netherlands
Alessandro Zuddas, M.D. University of Cagliari, Cagliari Italy
 
4.42
Obesity, Marijuana Use and Childhood ADHD: Prevalence of Adult Obesity in the MTA Follow-up Study
Kaitlyn A. LeMoine, B.A. Columbia University and New York State Psychiatric Institute, New York, NY
Elizabeth C. Dellario, B.S., M.A. Columbia University and New York State Psychiatric Institute, New York, NY
Laurence L. Greenhill, M.D. New York State Psychiatric Institute, New York, NY
 
4.43
Identifying Deficient Emotional Self-Regulation in ADHD Preschoolers Using Child Behavior Checklist and Teacher Report Form: A Pilot Study
Maria Grazia Melegari, M.D. Azienda Sanitaria Locale Roma A, Rome Italy
Roberto Sacco, Ph.D. Università Campus Bio-Medico, Rome Italy
Barbara Manzi, M.D. Università Campus Bio-Medico, Rome Italy
Elena Vittori, M.D. Centro Ricerche e Cura Balbuzie, Rome Italy
Antonio M. Persico, M.D. Università Campus Bio-Medico, Rome Italy
 
4.44
ADHD with Language Disorder in Preschoolers: Differences and Similarities with ADHD and SLI Disorders
Maria Grazia Melegari, M.D. Azienda Sanitaria Locale Roma A, Rome Italy
Loredana Canzano, Psy.D. Sapienza, University of Rome, Rome Italy
Marco Tullio Liuzza, Ph.D. IRCSS FONDAZIONE SANTA LUCIA, Rome Italy
Barbara Manzi, M.D. Università Campus Bio-Medico, Rome Italy
Roberto Sacco, Ph.D. Università Campus Bio-Medico, Rome Italy
 
4.45
Emotional Expression and Social Competence of Children with ADHD
Courtney M. Allem, B.A. University of California, Irvine, Irvine, CA
Natasha A. Emmerson, Ph.D. University of California, Irvine, Irvine, CA
Aness C. Kim, B.A. University of California, Irvine, Irvine, CA
Sabrina E. B. Schuck, Ph.D. University of California, Irvine, Irvine, CA
 
4.46
Modeling and Simulation of Guanfacine Extended-Release to Support Pediatric Trial Design
William Knebel, Ph.D., Pharm.D. Metrum Research Group, LLC, Tariffville, CT
Jim Rogers, Ph.D. Metrum Research Group, LLC, Tariffville, CT
Dan Polhamus, Ph.D. Metrum Research Group, LLC, Tariffville, CT
Sharon Youcha, M.D. Shire Development LLC, Wayne, PA
Carla White, M.S. Shire Pharmaceutical Development Ltd, Basingstoke United Kingdom
Jim Ermer, M.S. Shire Development LLC, Wayne, PA
Marc R. Gastonguay, Ph.D. Metrum Research Group, LLC, Tariffville, CT
 
4.47
Developmental and Contextual Considerations in Self-Control in ADHD
Julie B. Schweitzer, Ph.D. University of California, Davis School of Medicine, Sacramento, CA
Kyle Rutledge, B.S. University of California, Davis, Sacramento, CA
J. Faye Dixon, Ph.D. University of California, Davis School of Medicine, Sacramento, CA
Catherine Fassbender, Ph.D. University of California, Davis School of Medicine, Sacramento, CA
Wouter van den Bos, Ph.D. Stanford University, Stanford, CA
Tadeus Hartanto, B.S. University of California, Davis School of Medicine, Sacramento, CA
Lauren Boyle, B.A. University of California, Davis School of Medicine, Sacramento, CA
Samuel McClure, Ph.D. Stanford University, Stanford, CA
 
4.48
Does Parenting Stress Mediate the Association Between Child ADHD Symptoms and Treatment with Medication?
Elizaveta Bourchtein, B.A. Queens College, CUNY, Flushing, NY
Maria Rozon, B.A. Queens College, CUNY, Flushing, NY
Khushmand Rajendran, Ph.D. Queens College, CUNY, Flushing, NY
Jeffrey Halperin, Ph.D. Queens College, CUNY, Flushing, NY
 
4.49
Impact of Morning or Evening Dosing of Guanfacine Extended Release On Daytime Sleepiness in Children As Assessed by the Pediatric Daytime Sleepiness Scale
Ann C. Childress, M.D. Center for Psychiatry and Behavioral Medicine, Las Vegas, NV
Mark A. Stein, Ph.D. University of Illinois at Chicago, Chicago, IL
Carla White, M.S. Shire Pharmaceutical Development Ltd, Basingstoke United Kingdom
Gail Enright Shire Development LLC, Wayne, PA
Ryan Dammerman, M.D., Ph.D. Shire Development, LLC, Wayne, PA
 
4.50
EEG Correlates of Spatial Working Memory in ADHD
Agatha Lenartowicz, Ph.D. University of California Los Angeles, Los Angeles, CA
Patricia Walshaw, Ph.D. University of California, Los Angeles, Los Angeles, CA
James T. McCracken, M.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
James McGough, M.D. UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Arnaud Delorme, Ph.D. Swartz Center for Computational Neuroscience, Institute for Neural Computation, La Jolla, CA
Scott Makeig, Ph.D. University of California San Diego, San Diego, CA
Sandra K. Loo, Ph.D. University of California, Los Angeles, Los Angeles, CA
 
4.51
Impaired Visual Function in Adults with ADHD
Samantha Chen, B.S. Ontario Institute for Studies in Education of the University of Toronto, Toronto, ON
Soyeon Kim, M.A. University of Toronto, Toronto, ON
Kulanit Soontornsittipong Ontario Institute for Studies in Education of the University of Toronto, Toronto, ON
Hamed Dar Ontario Institute for Studies in Education of the University of Toronto, Toronto, ON
Rosemary Tannock, Ph.D. Ontario Intitute of Studies in Education, Toronto, ON
 
4.52
NWP06, a Novel, Extended-Release Methylphenidate Oral Suspension Demonstrates Efficacy in Permanent Product Measure of Performance (PERMP) Scores in Children with ADHD
Sharon Wigal, Ph.D. University of California, Irvine, Irvine, CA
Ann C. Childress, M.D. Center for Psychiatry and Behavioral Medicine, Las Vegas, NV
Heidi Belden, Pharm.D. NextWave Pharmaceuticals Inc, Cupertino, CA
 
4.53
Impaired Neural Processing in a Visual Working Memory Task During Encoding in Adults with ADHD
Daniel Glizer Ontario Institute for Studies in Education, Toronto, ON
Soyeon Kim, M.A. University of Toronto, Toronto, ON
Zhongxu Liu, M.A. Ontario Institute for Studies in Education, Toronto, ON
Rosemary Tannock, Ph.D. Ontario Intitute of Studies in Education, Toronto, ON
Steven Woltering, M.A. Ontario Institute for Studies in Education, Toronto, ON
 
4.54
Effects of Psychostimulant and Alpha 2 Agonist Medications On Resting State Cortical Activation in ADHD
Alexander L. Cho, B.S. University of California, Los Angeles, Los Angeles, CA
James T. McCracken, M.D. UCLA Semel Institute of Neuroscience and Human Behavior, Los Angeles, CA
James McGough, M.D. UCLA Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Sandra K. Loo, Ph.D. University of California, Los Angeles, Los Angeles, CA
 
4.55
The Impact of Improvements in Executive Functioning On Quality of Life in Adults with ADHD
Stephen L. Able, Ph.D. Eli Lilly and Company, Indianapolis, IN
Virginia S. Haynes Eli Lilly and Company, Indianapolis, IN
Allen W. Nyhuis Eli Lilly and Company, Indianapolis, IN
Paula T. Trzepacz Eli Lilly and Company, Indianapolis, IN
Deborah N. D'Souza PharmaNet/i3, Blue Bell, PA
Himanshu P. Upadhyaya, M.B.B.S., M.S. Eli Lilly and Company, Bellaire, TX
 
4.56
Period Prevalence of Stimulant Augmentation Among Pediatric ADHD Patients During 2009: A Retrospective Analysis of a Managed Care Population
Vanja Sikirica, M.P.H., Pharm.D. Shire Development LLC, Wayne, PA
Julia DiBello, Ph.D. Shire Pharmaceuticals, Inc., Wayne, PA
Keith A. Betts, Ph.D. Analysis Group, Inc., Boston, MA
Paul Hodgkins, M.S.C., Ph.D. Shire Development LLC, Wayne, PA
Zhou Zhou, M.S. Analysis Group, Inc., Boston, MA
Jipan Xie, M.D., Ph.D. Analysis Group, Inc., Boston, MA
Anthony DeLeon, M.S., Pharm.D. Shire Development, LLC, Round Rock, TX
M. Haim Erder, Ph.D. Shire Development LLC, Wayne, PA
Eric Q. Wu, Ph.D. Analysis Group, Inc., Boston, MA
 
4.57
Implementing Evidence-Based Diagnostic and Treatment Practices in a Child and Adolescent ADHD Clinic
Jyoti Bhagia, M.D. Mayo Clinic, Rochester, MN
Kumi Yuki, M.D. Mayo Clinic, Rochester, MN
Peter S. Jensen, M.D. Mayo Clinic, Rochester, MN
 
4.58
Study about the Stigma of Teachers in Secondary School on the Students with ADHD
Fernando Félix, M.D. National Institute of Psychiatry, Mexico Mexico
Lino Palacios M.D., M.S. Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City Mexico
Francisco De la Peña, M.D. Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City Mexico
 
4.59
Findings From the Implementation of the Texas ADHD Medication Algorithm in a Canadian Clinic
Daniel J. Wagner University of Calgary, Calgary, AB
John McLennan, M.D., Ph.D. University of Calgary, Calgary, AB
 
4.60
Feasibility of Conducting a Randomized Trial of Telepsychiatry: The End Is in Sight
L. Lee Carlisle, M.D. Seattle Children's Hospital and University of Washington, Seattle, WA
Caitlin Lobdell, B.S. Seattle Children's Research Institute, Seattle, WA
Carol Rockhill, M.D., M.P.H., Ph.D. Seattle Children's Hospital Bellevue, Bellevue, WA
William French, M.D. University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA
Heather Violette, Ph.D. Seattle Children's Research Institute, Seattle, WA
Ann Vander Stoep, Ph.D. University of Washington School of Medicine and Public Health, Seattle, WA
Kathleen Myers, M.D., M.P.H., M.S. University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA
 
4.61
Psychotropic Medication Persistence in a Large Managed Care Medicaid Program: Do Child-, Parent- or System-Level Factors Matter?
Bonnie Zima, M.D., M.P.H. UCLA Center for Health Services Research & Society, Los Angeles, CA
Regina Bussing, M.D. University of Florida College of Medicine, Gainesville, FL
Susan DosReis, Ph.D. University of Maryland School of Pharmacy, Baltimore, MD
Lily Zhang, M.S. UCLA Center for Health Services & Society, Los Angeles USA
Linqgi Tang, Ph.D. UCLA Center for Health Services Research & Society, Los Angeles, CA
 
4.62
Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children and Adolescents with Dyslexia or ADHD and Comorbid Dyslexia
Sally Shaywitz, M.D. Yale University School of Medicine, New Haven, CT
Bennett Shaywitz, M.D. Yale University School of Medicine, New Haven, CT
Linda Wietecha, M.S. Eli Lilly and Company, Indianapolis, IN
Sharon Wigal, Ph.D. University of California, Irvine, Irvine, CA
Keith McBurnett, Ph.D. University of California, San Francisco, San Francisco, CA
David Williams, M.S. PharmaNet/i3, Indianapolis, IN
William Kronenberger, Ph.D. Indiana University School of Medicine, Indianapolis, IN
Stephen R. Hooper, Ph.D. University of North Carolina School of Medicine, Carrboro, NC
 
4.63
Gender Effects On the Biology of ADHD
Allison Gruber Columbia College of Physicians and Surgeons and New York State Psychiatric Institute, New York, NY
Jonathan Posner, M.D. Columbia University, New York, NY
Bradley S. Peterson, M.D. New York State Psychiatric Institute and Columbia University, New York, NY
Virginia Rauh, Ph.D. Columbia College of Physicians and Surgeons, New York, NY
 
4.64
Social Responsiveness in Children and Adolescents with ADHD
Laura Anchisi, M.D. Cagliari University Hospital Center for Pharmacological Therapies in Child and Adolescent Neuropsychiatry, Cagliari Italy
Sara Carucci, M.D. Cagliari University Hospital Center for Pharmacological Therapies in Child and Adolescent Neuropsychiatry, Cagliari Italy
Laura Lecca, M.D. Struttura complessa di Neuropsichiatria dell'Infanzia e dell'Adolescenza (UONPIA) Mantova, Mantova Italy
Giovanni Ambu, Sc.M. Cagliari University Hospital Center for Pharmacological Therapies in Child and Adolescent Neuropsychiatry, Cagliari Italy
Alessandro Zuddas, M.D. University of Cagliari, Cagliari Italy

See more of: New Research Poster